Trial · NCT06002490
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of Subjects Who Achieved Durable Phlebotomy-free Complete Hematological Response (CHR) at Week 24 | 24 weeks | |
| Secondary | Rate of achieving "phlebotomy-free complete hematologic response (CHR)" (the same criteria as for the primary efficacy endpoint) at both Week 12 and Week 24. | Week12, Week24 | |
| Secondary | Time to achieve CHR | Up to Week24 | |
| Secondary | Time to reach response maintenance dose (three consecutive doses of the same dose) | Up to Week24 | |
| Secondary | Numbers of phlebotomy required and changes in numbers of phlebotomy required from baseline | Baseline, up to Week24 | |
| Secondary | Time to first response in peripheral blood count (Hct, WBC, and PLT) | Up to Week24 | |
| Secondary | Duration of response in peripheral blood count (Hct, WBC, and PLT) | Up to Week24 | |
| Secondary | Improvement of symptoms assessed by MPN-SAF TSS at each visit | Up to Week24 | Rated on a scale of 0-10 on an 11-point scale, with 0 being no symptoms, 1 being the best, and 10 being the worst. |
| Secondary | Proportion of subjects without thrombotic or hemorrhagic events at Weeks 12 and 24 | Week12, week24 | |
| Secondary | Change from baseline to Week 24 in JAK2 V617F allele burden level | Baseline, week24 | |
| Secondary | Collect and measure Pharmacokinetics (PK) at trough | Day1, Week2, Week4, Week6, Week8, Week10, Week12, Week14, Week16, Week18, Week20, Week22, Week24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06002490/registered